Abstract
Significant anti-HCV activity of 6-hetarylpurine ribonucleosides has been discovered and is reported here for the first time and compared with cytostatic effect. An extended series of 6-hetarylpurine nucleosides has been prepared by heterocyclizations in position 6 of purine nucleosides or by cross-couplings of 6-chloropurine nucleosides with hetarylboronic acids, -stannanes, or -zinc halides. The most anti-HCV active were purine ribonucleosides bearing pyrrol-3-yl or 2-furyl groups exerting EC(90) = 0.14 and 0.4 microM, respectively.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
Antiviral Agents / chemical synthesis*
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology
-
Cell Line, Tumor
-
Drug Screening Assays, Antitumor
-
Hepacivirus / drug effects*
-
Humans
-
Mice
-
Purine Nucleosides / chemical synthesis*
-
Purine Nucleosides / chemistry
-
Purine Nucleosides / pharmacology
-
Ribonucleosides / chemical synthesis*
-
Ribonucleosides / chemistry
-
Ribonucleosides / pharmacology
-
Structure-Activity Relationship
Substances
-
Antineoplastic Agents
-
Antiviral Agents
-
Purine Nucleosides
-
Ribonucleosides